Get started
Author

Tamara J. Dunn

Observed names: T Dunn, Tamara Dunn
ORCID: 0000-0002-3813-0092
Observed ORCID: 0000-0002-3813-0092
OpenAlex ID: A5081323335
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
2019 · Haijiao Zhang, Beth Wilmot, et al. · Blood · 85
Effect of Fitbit and iPad Wearable Technology in Health-Related Quality of Life in Adolescent and Young Adult Cancer Patients
2018 · Ilana R. Yurkiewicz, Pamela Simon, et al. · Journal of Adolescent and Young Adult Oncology · 41
Hemophagocytic lymphohistiocytosis in pregnancy: a case report and review of treatment options
2012 · Tamara Dunn, May Cho, et al. · Hematology · 39
PDF
A Social Media‒Based Public Health Campaign Encouraging COVID-19 Vaccination Across the United States
2022 · Isabella de Vere Hunt, Tamara Dunn, et al. · American Journal of Public Health · 30
Salvage therapy with mitoxantrone, etoposide and cytarabine in relapsed or refractory acute lymphoblastic leukemia
2014 · Michaela Liedtke, Tamara Dunn, et al. · Leukemia Research · 19
A social media-based campaign to promote COVID-19 vaccine uptake in underrepresented groups in the US
2021 · I de Vere Hunt, T Dunn, et al. · European Journal of Public Health · 11
PDF
Say My Name: Understanding the Power of Names, Correct Pronunciation, and Personal Narratives
2022 · Salma Dali, Anaid Atasuntseva, et al. · MedEdPORTAL · 10
Gender differences in question-asking at the 2019 American Society of Hematology Annual Meeting
2020 · Saira Moazzam, Lynn Onstad, et al. · Blood Advances · 10
PDF
Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response
2017 · Caner Saygin, Nikolaos Papadantonakis, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 7
Underrepresented in Medicine Trainees’ Sense of Belonging and Professional Identity Formation after Participation in the Leadership Education in Advancing Diversity Program
2024 · Lahia Yemane, Carmin Powell, et al. · Academic Pediatrics · 6
A phase 1, open‐label, dose‐escalation study of pralatrexate in combination with bortezomib in patients with relapsed/refractory multiple myeloma
2016 · Tamara J. Dunn, Shira Dinner, et al. · British Journal of Haematology · 3
The Impact of Distance to Treatment Center on the Outcome of AML
2010 · Bruno C. Medeiros, Tamara J. Dunn, et al. · Blood · 3
Barriers and Facilitators to the Success of Black Academic Physicians
2024 · Barbara Jerome, Magali Fassiotto, et al. · Journal of Racial and Ethnic Health Disparities · 2
Change In Albumin Levels During Induction Predicts Survival Outcomes In Adult Acute Lymphoblastic Leukemia
2013 · Kimberly Komatsubara, Tamara J. Dunn, et al. · Blood · 2
Successful type A aortic dissection repair in the setting of severe immune thrombocytopenia
2022 · Aleena Yasin, Melissa G. Medina, et al. · JTCVS Open · 1
PDF
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma
2018 · Shira Dinner, Tamara J. Dunn, et al. · International Journal of Hematology · 1
Impact of Day 28 Absolute Lymphocyte Count On Outcome of Hematopoietic Cell Transplant (HCT) in CR1 for Adult Patients with Acute Lymphoblastic Leukemia
2012 · Jonathan A Rose, Tamara J. Dunn, et al. · Blood · 1
Prognostic Parameters in Adults with Acute Lymphoblastic Leukemia at Second Complete Response
2016 · Caner Saygin, Nikolaos Papadantonakis, et al. · Blood
Amrubicin, a Novel Investigational Anthracycline, in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma: Results of a Phase 1 Dose-Escalation Study
2012 · Shira N. Dinner, Tamara J. Dunn, et al. · Blood
A Phase I/II Study of Bortezomib (VELCADE) in Combination with Pralatrexate in Relapsed/Refractory Multiple Myeloma
2012 · Tamara J. Dunn, Shira N. Dinner, et al. · Blood
Works count: 20
Citation count: 271
H-index: 8
I10-index: 8
Year
Topic
Type